儿童抗脑膜炎球菌疫苗接种 - - 欧洲视角
Lisbeth M Næss1, Sara V Watle2
1Department of Infection Control and Vaccines, Division of Infection Control, Norwegian Institute of Public Health, Oslo, Norway.
Acta paediatrica (Oslo, Norway : 1992)
|August 7, 2025
概括
侵入性脑膜炎球菌病 (IMD) 监测对于疫苗推至关重要,因为流行病学不可预测. 持续监测Neisseria meningitidis菌株,并在国家计划中考虑疫苗至关重要.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 细菌学 细菌学是一门学科.
背景情况:
- 侵袭性脑膜炎球菌病 (IMD),由内菌引起,不成比例地影响儿童.
- IMD流行病学是不可预测的,因地理位置,年龄和血清组而异,需要严格的监测.
- 虽然疫苗接种减少了发病率,但像法国这样的某些地区面临着病例数量的上升.
研究的目的:
- 突出IMD监测对于为疫苗策略提供信息的重要性.
- 强调需要继续监测尼塞利亚脑膜炎的流行病学.
- 倡导将脑膜炎球菌疫苗纳入国家免疫计划.
主要方法:
- 对IMD流行病学趋势的分析.
- 对尼塞利亚脑膜炎菌株数据的审查.
- 评估当前脑膜炎球菌疫苗的有效性和安全性.
主要成果:
- 由于疫苗接种努力,IMD发病率普遍下降.
- 各国和人口统计数据之间存在IMD流行病学的显著差异.
- 法国最近报告IMD病例的增加.
结论:
- 有效的脑膜炎球菌疫苗可用,具有良好的安全性.
- 在整个欧洲,应该考虑将脑膜炎球菌疫苗纳入国家免疫计划.
- 持续监测Neisseria meningitidis菌株对于保护公众健康至关重要.
相关概念视频
Vaccinations
45.3K
Overview
45.3K
Microorganisms in Medicine and Therapeutics
337
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
337
Healthcare Associated Infections II: Preventive Measures
2.8K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.8K


